Kriti Nutrients Ltd Upgraded to Hold on Improved Valuation and Financial Metrics

Valuation Upgrade Drives Rating Change

The primary catalyst for Kriti Nutrients’ rating upgrade is the shift in its valuation grade from fair to attractive. The company currently trades at a price-to-earnings (PE) ratio of 13.89, which is favourable compared to many peers in the edible oil industry. For context, competitors such as AVT Natural Products and Gokul Refoils trade at higher PE ratios of 16.2 and 22.49 respectively, while Kriti’s EV to EBITDA ratio stands at 9.78, indicating relatively better earnings efficiency on an enterprise value basis.

Other valuation metrics reinforce this attractive positioning: a price-to-book value of 2.06 and an enterprise value to capital employed ratio of 2.33. The company’s PEG ratio remains at 0.00, signalling that earnings growth expectations are not currently priced into the stock, which could present upside potential if growth improves. Additionally, Kriti Nutrients offers a dividend yield of 3.51%, providing income appeal to investors.

Financial Trend: Mixed Signals Amid Flat Quarterly Results

While the valuation has improved, Kriti Nutrients’ recent financial performance has been subdued. The company reported flat results in Q4 FY25-26, with profit after tax (PAT) at ₹6.36 crores, down 21.7% compared to the previous four-quarter average. Profit before tax excluding other income (PBT less OI) also declined by 9.5% to ₹7.68 crores. These figures highlight short-term headwinds impacting profitability.

Over the longer term, the company’s net sales have grown at a modest compound annual growth rate (CAGR) of 5.96% over five years, while operating profit has expanded at a healthier 14.96% CAGR. However, the stock’s one-year return of -18.26% significantly underperformed the broader market, with the BSE500 index falling only 2.06% in the same period. This underperformance reflects both sector-specific challenges and company-specific profit pressures.

Quality Assessment: Strong Management Efficiency and Low Leverage

Kriti Nutrients continues to demonstrate high management efficiency, reflected in its return on equity (ROE) of 14.8% and return on capital employed (ROCE) of 18.68%. These metrics indicate effective utilisation of shareholder funds and capital to generate profits. The company’s debt-to-equity ratio remains low at 0.06 times on average, underscoring a conservative capital structure that limits financial risk.

Despite the flat quarterly results, the company’s ability to maintain strong returns on equity and capital employed supports the Hold rating, signalling resilience in operational quality and governance.

Technicals and Market Performance

From a technical perspective, Kriti Nutrients’ stock price has shown volatility, closing at ₹94.00 on 2 June 2026, down 3.59% from the previous close of ₹97.50. The stock’s 52-week high stands at ₹125.00, while the low is ₹52.25, indicating a wide trading range over the past year. The current price is closer to the mid-range, suggesting some consolidation after recent declines.

In terms of returns, Kriti Nutrients has outperformed the Sensex over longer horizons, with a 5-year return of 122.75% compared to the Sensex’s 43.00%, and a remarkable 10-year return of 416.48% versus the Sensex’s 178.01%. However, the recent one-year underperformance highlights near-term challenges that investors should monitor closely.

Peer Comparison and Industry Context

Within the edible oil sector, Kriti Nutrients’ valuation metrics place it favourably among peers. For instance, BCL Industries and KSE enjoy very attractive valuations with PE ratios of 8.19 and 7.23 respectively, but Kriti’s valuation remains competitive given its higher ROCE and dividend yield. Conversely, companies like Shri Venkatesh and Yashhtej Industries trade at expensive multiples, with PE ratios exceeding 11 and EV to EBITDA ratios above 10.

This relative valuation attractiveness, combined with solid returns on equity and capital employed, supports the upgraded Hold rating despite the company’s micro-cap status and recent profit pressures.

Outlook and Investor Considerations

Investors should weigh Kriti Nutrients’ attractive valuation and strong management efficiency against the backdrop of flat recent earnings and underperformance over the past year. The company’s dividend yield of 3.5% offers some cushion, but the subdued sales growth and profit decline in the latest quarter warrant caution.

Long-term investors may find value in the stock’s attractive multiples and historical outperformance over multi-year periods, but near-term volatility and sector headwinds suggest a Hold stance until clearer signs of earnings recovery emerge.

Summary of Rating Parameters

Quality: Maintained at a solid level with ROE of 14.8% and ROCE of 18.68%, supported by low leverage (debt-to-equity 0.06).

Valuation: Upgraded from fair to attractive due to a PE ratio of 13.89, price-to-book of 2.06, and EV/EBITDA of 9.78, offering relative value versus peers.

Financial Trend: Mixed signals with flat Q4 FY25-26 results and a one-year profit decline of 8.6%, but moderate long-term sales and operating profit growth.

Technicals: Stock price near ₹94 with a 52-week range of ₹52.25 to ₹125.00, showing recent weakness but long-term outperformance versus Sensex.

The upgrade to Hold reflects a balanced view, recognising valuation improvement and quality metrics while acknowledging recent earnings softness and market volatility.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →